1983
DOI: 10.1016/0006-2952(83)90220-4
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the action of nitroimidazole drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

1984
1984
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(12 citation statements)
references
References 24 publications
1
11
0
Order By: Relevance
“…Through reductive processes, nitroaromatic compounds are often converted to the corresponding amines (Heimbrook and Sartorelli 1986; Kennedy et al 1980; Knox et al 1983), whereas the reduction of benzofurazans can involve a ring-opening event (Stradyn et al 1974; Tsveniashvili et al 1966). In the case of NBF-SPh, redox-cycling may involve either of the two reductive pathways, and delineation of this mechanism would contribute to the design of future BFZs.…”
Section: Resultsmentioning
confidence: 99%
“…Through reductive processes, nitroaromatic compounds are often converted to the corresponding amines (Heimbrook and Sartorelli 1986; Kennedy et al 1980; Knox et al 1983), whereas the reduction of benzofurazans can involve a ring-opening event (Stradyn et al 1974; Tsveniashvili et al 1966). In the case of NBF-SPh, redox-cycling may involve either of the two reductive pathways, and delineation of this mechanism would contribute to the design of future BFZs.…”
Section: Resultsmentioning
confidence: 99%
“…After removal of LC-MS artefacts and known contaminants, measured exact masses were compared with theoretical exact masses of Bzn derived metabolites contained in Bznmet database (“targeted sheet”, Files S1 and S2). This database included reported and putative Bzn reduction products and covalent adducts of Bzn with small cellular metabolites, all retrieved from existing reports on in vivo and in vitro modification processes for Bzn and similar nitroimidazoles, covering enzymatic and non-enzymatic conversions [17], [25], [26], [27]. Accurate mass and relative isotope abundance was used to determine the chemical formulae for the remaining unidentified metabolites detected specifically in the 50 µM Bzn treated samples.…”
Section: Methodsmentioning
confidence: 99%
“…For example, it was suggested that the corresponding hydroxylamine derivative obtained by the reduction is the active form of the drug. 64 In this context, it should be noted that the nitro group can be eliminated in the reduction of Met ronidazole. [63][64][65] For instance, it is known that the electrolysis of Met ronidazole affords nitrite ions in high yield; 65 the reduc tion of the drug in solution in the presence of thiols and divalent iron ions gives complexes containing iron ions, molecules of thio derivatives, and nitric oxide.…”
Section: Scheme 70mentioning
confidence: 99%
“…64 In this context, it should be noted that the nitro group can be eliminated in the reduction of Met ronidazole. [63][64][65] For instance, it is known that the electrolysis of Met ronidazole affords nitrite ions in high yield; 65 the reduc tion of the drug in solution in the presence of thiols and divalent iron ions gives complexes containing iron ions, molecules of thio derivatives, and nitric oxide. 66 It should be emphasized that N substituted 5 nitro 2 styrylimidazoles in alkaline media (pH > 10) undergo the cleavage accompanied by the opening of the imidazole ring and elimination of the nitro group as the nitrite an ion.…”
Section: Scheme 70mentioning
confidence: 99%